Details for 2021164923
Up to date per 04.04.2026
Actions
Details for 2021164923
Granted/Registered
European Patent
22.12.2021 A
04.06.2025 B1
17.06.2016
US
201662351841 P
C12N 9/64 20060101AFI20211118BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
No representatives present
Inventor
KARBARZ, Mark South San Francisco, CA 94080US
CONLEY, Pamela B. South San Francisco, CA 94080US
LU, Genmin South San Francisco, CA 94080US
Information about Fees